STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE

被引：0
|
作者：
Kumar, S. [1 ]
Lacy, M. Q. [1 ]
Dispenzieri, A. [1 ]
Hayman, S. R. [1 ]
Dingli, D. [1 ]
Miceli, T. [1 ]
Litzow, M. R. [1 ]
Rajkumar, S. V. [1 ]
Gertz, M. A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.205
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
177
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma
    Forsberg, Peter A.
    Rossi, Adriana C.
    Boyer, Angelique
    Pearse, Roger N.
    Pekle, Karen A.
    Jayabalan, David
    Lakritz, Stephanie
    Flicker, Kari
    Ribadeneyra, Drew
    Liotta, Brielle
    Ely, Scott
    Boussi, Leora
    Allan, John N.
    Coleman, Morton
    Niesvizky, Ruben
    Mark, Tomer M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1554 - 1562
  • [32] ADEQUATE MOBILIZATION OF CD34 IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE INDUCTION THERAPY
    Palumbo, A.
    Ben Yehuda, D.
    Cavallo, F.
    Bringhen, S.
    Di Bello, C.
    Di Raimondo, F.
    Hardan, I.
    Petrucci, M. T.
    Siniscalchi, A.
    Rossini, F.
    Montefusco, V.
    Pescosta, N.
    Peccatori, J.
    Tacchetti, P.
    Baraldi, A.
    Patriarca, F.
    Benevolo, G.
    Crippa, C.
    Carella, A. M.
    Boccadoro, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 288 - 288
  • [33] Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma
    O'Gorman, Peter
    Laubach, Jacob P.
    O'Dwyer, Michael E.
    Krawczyk, Janusz
    Yee, Andrew J.
    Gilligan, Oonagh
    Cahill, Mary R.
    Rosenblatt, Jacalyn
    Quinn, John
    Murphy, Philip T.
    DiPietro, Heidi
    Perera, Meegahage Ratnakanthi
    Crotty, Gerard M.
    Cummings, Kristen
    Hayden, Patrick J.
    Browne, Paul
    Savell, Alexandra
    O'Leary, Hilary M.
    O'Keeffe, Denis
    Masone, Kelly
    Hennessy, Brian J.
    Garcia, Thomas Guerrero
    Scott, Kathleen
    Saeed, Khalid
    Bianchi, Giada
    Dowling, Paul
    Tierney, Ciara
    Richardson, Paul G.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (05) : 562 - 573
  • [34] Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma
    Mizuno, Shinichi
    Kitayama, Chigusa
    Mashiko, Shigeto
    Sanada, Satoru
    [J]. CEN CASE REPORTS, 2022, 11 (02) : 265 - 268
  • [35] Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma
    Shinichi Mizuno
    Chigusa Kitayama
    Shigeto Mashiko
    Satoru Sanada
    [J]. CEN Case Reports, 2022, 11 : 265 - 268
  • [36] Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
    McCaughan, Georgia J.
    Gandolfi, Sara
    Moore, John J.
    Richardson, Paul G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 190 - 204
  • [37] Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
    Liang, Dong
    Bai, Shenrui
    Feng, Demei
    Chen, Guanjun
    Liang, Yang
    Wang, Hua
    [J]. BMC CANCER, 2024, 24 (01)
  • [38] Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma
    Knop, S.
    Langer, C.
    Engelhardt, M.
    Muegge, L-O
    Reichle, A.
    Roesler, W.
    Bassermann, F.
    Hertenstein, B.
    Kunitz, A.
    Roellig, C.
    Ostermann, H.
    Schaefer-Eckart, K.
    Ringhoffer, M.
    Guenther, A.
    Junghanss, C.
    Biersack, H.
    Schreder, M.
    Liebert, A.
    Held, S.
    Einsele, H.
    Bargou, R. C.
    [J]. LEUKEMIA, 2017, 31 (08) : 1816 - 1819
  • [39] Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma
    S Knop
    C Langer
    M Engelhardt
    L-O Mügge
    A Reichle
    W Rösler
    F Bassermann
    B Hertenstein
    A Kunitz
    C Röllig
    H Ostermann
    K Schäfer-Eckart
    M Ringhoffer
    A Günther
    C Junghanss
    H Biersack
    M Schreder
    A Liebert
    S Held
    H Einsele
    R C Bargou
    [J]. Leukemia, 2017, 31 : 1816 - 1819
  • [40] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    [J]. BLOOD, 2009, 114 (22) : 1494 - 1495
12345